CA2462254A1 - Devices for treating atrial fibrilation - Google Patents
Devices for treating atrial fibrilation Download PDFInfo
- Publication number
- CA2462254A1 CA2462254A1 CA002462254A CA2462254A CA2462254A1 CA 2462254 A1 CA2462254 A1 CA 2462254A1 CA 002462254 A CA002462254 A CA 002462254A CA 2462254 A CA2462254 A CA 2462254A CA 2462254 A1 CA2462254 A1 CA 2462254A1
- Authority
- CA
- Canada
- Prior art keywords
- scaffold
- heart
- platform
- platform scaffold
- creating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/50—Supports for surgical instruments, e.g. articulated arms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22097—Valve removal in veins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320052—Guides for cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/904—Heart
Abstract
The devices of the present invention form a platform, or scaffold for the precise delivery of various forms of energy for treatment of atrial fibrilation. Additionally, the devices of the present invention form a scaffold for the precise delivery of fluids to surrounding tissues. The use of additional energy sources can improve the delivery of various fluids into the surrounding tissue.
Description
2 PCT/US02/31374 METHODS AND DEVICES FOR TREATING ATRIAL FIBRILATION
REFERENCE TO PENDING PRIOR PATENT APPLICATION
This patent application claims benefit of pending prior U.S. Provisional Patent Application Serial Number 60/326,590 filed October 1, 2001 by John A.
Macoviak, which patent is hereby incorporated by reference.
FIELD OF THE INVENTION
This invention relates to methods and devices to improve the function of the heart. More particularly, the invention relates to methods and devices to treat atrial fibrillation.
BACKGROUND OF THE INVENTION
To function properly as a pump, the heart must contract in a rhythmic pattern.
Heart rhythm is normally established at a single point called the sinoatrial node, or SA node, located in the right atrium of the heart, near the opening of the superior vena cava. The SA node generates electrical impulses which spread throughout the heart and result in a rhythmic contraction of the heart, termed a sinus rhythm. Thus, the SA node functions as a pacemaker for the heart.
Other regions of the heart can potentially produce electrical impulses. A
pacemaker other than the SA node is referred to as an ectopic pacemaker. Electrical signals from an ectopic pacemaker can disrupt a rhythmically contracting heart, resulting in an arrhythmia, characterized by a chaotic, disorganized heart rhythm. Fibrillation of the atria results in loss of atrial contraction and rapid impulses being sent to the ventricles causing high and irregular heart rates.
Atrial fibrillation (AF) is clinically related to several conditions, including anxiety, increased risk of stroke, reduced exercise tolerance, cardiomyopathy, congestive heart failure and decreased survival. Patients who experience AF are, generally, acutely aware of the symptoms.
Current curative AF therapies are based upon a procedure that has become known as the Cox Maze procedure. The Cox Maze procedure is an open-heart, surgical procedure that requires the patient to be placed on cardiopulmonary bypass equipment. The procedure requires six hours and the patient to be under general anesthesia. In this procedure, access to the heart is gained by way of a median sternotomy, which is a surgical split of the breast bone. The left atrium is surgically incised along predetermined lines known to be effective in blocking the transmission of electrical signals from an ectopic pacemaker that triggers AF.
The incision lines create blocks that prevent conduction of unwanted electrical signals throughout the heart and permit a normal pattern of depolarization of the atria and ventricles beginning in the SA node and traveling to the AV or atrioventricular node.
Less invasive methods and devices for treating AF are needed that improve heart function and improve patient safety.
SUMMARY OF THE INVENTION
The devices of the present invention form a platform, or scaffold for the precise delivery of various forms of energy for treatment of atrial fibrilation. Additionally, the devices of the present invention form a scaffold for the precise delivery of fluids to surrounding tissues. The use of additional energy sources can improve the delivery of various fluids into the surrounding tissue.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows an embodiment of the invention in relation to its position within the heart, and within a patient's body.
Figure 2 shows an enlarged view of the device of Figure 1, with the loops surrounding the outlet of the pulmonary veins 210.
Figure 3 shows the reverse side of the device of Figures l and 2. The reverse side's loop section 320 is shown having a multitude of holes, or micro-ports 330, that lie adjacent to the atrial walls.
Figure 4 shows an embodiment of the invention 400, in fluid communication with a catheter 410.
Figure 5 show an embodiment of the device shown in Figure 4 Figure 6 is a frontal view of the device of Figures 4 and 5, with an additional positioning element.
Figure 7 is a longitudinal cross section of one embodiment of a tubule 720, having several micro-ports 730.
Figure 8 shows a radial cross section of the tubule shown in Figure 7.
Figures 9 and 10 show alternative tubule 910 designs, wherein the micro-ports are filled with porous plugs 920.
Figure 11 shows a catheter being introduced from the inferior vena cava 1110, into the right atrium 1140, through a septum 1120 between the right and left atrium, and into the left atrium 1150.
Figure 12 illustrates an embodiment of the invention 1200 that may be used to deliver energy to designated tissue.
Figure 13 shows an embodiment of the invention, and the use of an energy source 1310 to deliver energy to devices of the present invention.
Figure 14 shows an embodiment of the invention 1400 having a positioning structure 1410 to standardize scaffold orientation within a treated heart chamber.
Figure 15 shows a scaffold in the form of a wire coil that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium in the example shown.
Figure 16 shows another embodiment for the scaffold 1600 of present invention.
The scaffold is in the form of a wire cage that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium.
Figure 17 shows another embodiment for the scaffold 1700 of present invention.
Figure 18 illustrates an alternative embodiment 1800 of the invention, positioned within the right atrium.
Figures 19 through 22 show various embodiments of the invention having dual chamber structures.
Figures 23-25 show schematic views of a patient with a catheter 2340 being advanced from the inferior vena cava 2330, into the right atrium, and across the septum into the left atrium.
A second catheter 2320 is being advanced through the esophagus 2320.
DETAILED DESCRIPTION
Figure 1 shows an embodiment of the invention in relation to its position within the heart, and within a patient's body. The device 100 is comprised of a platform, or scaffold that is shown being introduced from the inferior vena cava 150, into the right atrium 190, across the septum 115 between the right and left atrium, and into the left atrium 180. The device 100 scaffold is shown having a right ablation loop 120, a left ablation loop 130, and an annular base 140. The right and left ablation loops are shown to come within close proximity of the atrial walls that surround the pulmonary veins. The pulmonary veins are common sources of ectopic pacemakers.
S The device 100 is advanced through a catheter 110 and into position.
Alternatively, the device 100 may be pre-loaded within a delivery catheter.
Figure 2 shows an enlarged view of the device of Figure 1, with the loops surrounding the outlet of the pulmonary veins 210. The device may be used as a temporary platform, or scaffold, from which therapeutic fluids or energy can be deployed.
Alternatively, the device may be left in place as a permanent implant.
Although the device 200 may have a gap of incomplete contact between the device and target tissue, the device is still effective, as described below, especially when used conjunction with tissue disrupting energies (electroporation or sonoporation), energies that promote fluid flow (electrophoresis or sonophoresis), and energies that promote scaffold vibrations. Many types of energies can be delivered to the scaffold either directly, or indirectly. Indirect application (using non-contact means) of energies can be applied trans-esophageally, trans-bronchially, trans-tracheally, trans-thoracically, across the sternum, etc.
Figure 3 shows the reverse side of the device of Figures 1 and 2. The reverse side's loop section 320 is shown having a multitude of holes, or micro-ports 330, that lie adjacent to the atrial walls. The micro-ports can be laser cut along the mural facing surface of the device. The micro-ports direct fluids within the device to be released into adjacent tissues. Fluids within the device may include alcohol, potassium iodide, therapeutic drugs, etc.
Alternatively, the devices of the present invention may not have any micro-ports, and instead be used as a heat exchanger. For example, a heat removing fluid could be circulated within the device, thus giving rise to a temporary conduction block in the adjacent tissue. As such, the device 300 can be used a diagnostic tool, for determining the origin of ectopic pacemakers, for example. Also, with longer exposures to adjacent tissues, the heat removal aspect of the device could result in permanent conduction block, tissue shrinkage (to tighten the skin, for promoting valve function, or close off an atrial appendage), etc.
When used in the left atrium, the device's annular base 310 is positioned to surround the mural annulus. The loop section 320 is supported by upright members 315. The loop section 320 is in fluid communication with the catheter via the inlet port 340.
As shown, this device may be used to prevent AF, but in a manner that differs from the Cox Maze procedure. In the Cox Maze procedure, a specific pattern is cut into the heart to create a proper pathway for the signal generated from the SA node to travel throughout the heart. The device shown differs in that it does not create a signal pathway, but rather isolates unwanted signals from propagating. The procedure is intended for use by an interventional electro-cardiologist, or other skilled professional.
Figure 4 shows an embodiment of the invention 400, in fluid communication with a catheter 410. The catheter 410 may be introduced into the femoral vein, and advanced through the vena cava into the right atrium. The catheter may be 12 to 14 French in diameter and approximately 1 SO centimeters long, depending on the dimensions of the patient's anatomy. An exemplary catheter 410 is shown to have a guide wire port 420, a thru lumen port 430, and an ablation agent vent 440. Not shown is an ablation agent inlet port. Preferred ablation agents are alcohol, or potassium iodide.
The catheter may be introduced into the patient under fluoroscopic guidance and advanced through the venous return to the right atrium of the heart. Using standard cardiology procedures, a trans-septal puncture will be performed and the catheter 410 may be advanced through the trans-septal puncture into the left atrium. Guide wires may be advanced into the atrial appendage, the mural valve annulus and one of the pulmonary veins. The device is preferably designed from a biocompatible, super-elastic material that will expand aggressively under the effects of body heat, or with the aid of an inflatable balloon.
Under continued fluoroscopic guidance with the adjunctive capability for verification by intravascular ultrasound, the cardiologist will ensure that the device has expanded completely, and is positioned correctly and in close contact with surrounding heart wall. The device is then used as a platform for the delivery of energy or a fluid that can create a conduction block, or be used diagnostically.
Conduction block lines preferably fully transect the myocardium of the atrium (about 3 to S
millimeters in thickness). Once the conduction block has been completed, the device may be removed from the patient.
The benefits of using alcohol, or other tissue fixative agents, is the drastic reduction of energy required to create conduction block, resulting in a safer and more effective ablation because the tissue is in fact toughened by the fixative properties of alcohol-like agents that cause a coagulation cellular necrosis instead of a weakened tissue wall liquefaction necrosis that is caused with other types of energy to create conduction block.
Figure 5 show an embodiment of the device shown in Figure 4. The device is shown with an opposition member 540, a superior tubule 530 (superior relative to the pulmonary veins), and an inferior tubule 560 (inferior relative to the pulmonary veins). In addition, the device can be designed with additional tubules to create additional lines of ablation, or additional opposition S members. Assuming a traps-septal introduction of this embodiment from the right atrium into the left atrium, the proximal end 520 of the device is positioned adj acent the traps-septal entry point. The opposition member 540 is positioned along the anterior wall, opposite the pulmonary veins. The opposition member functions to transmit mural pressure from the atrium through the device to the tubules. The superior tubule, 530, is positioned adjacent the apex of the left atrium.
The inferior tubule, 560, is positioned adjacent the base of the posterior wall. The tubules, 530 and 560, have a multitude of micro-ports 500. The micro-ports allow a fluid to be released from inside the tubules and into the atrial walls. Several fluids can be used, any of which function to disrupt the flow of unwanted electrical signals. Thus, the fluids released from the micro-ports located along the tubules create an electrical signal block. The shape of signal block created by this embodiment is that of an oval, or a football. The lines follow a path similar to two adjacent longitudinal lines on a world globe (turned sideways) beginning at the North Pole, and ending at the South Pole.
Figure 6 is a frontal view of the device of Figures 4 and 5. An additional aspect of the device includes an orienting structure, so that the device takes advantage of anatomical features to achieve proper orientation within a heart chamber. For example, Figure 6 shows a circular structure 600 projecting from the distal end of the device. This circular projection may be positioned within an atrial appendage to aid with orientation of the device.
This may be designed in the shaped of a pigtail, or corkscrew projecting from the distal end of the device.
Figure 7 is a longitudinal cross section of one embodiment of a tubule 720, having several micro-ports 730. The tubule 720 is encased within a sleeve 710. A
preferred sleeve 710 is a polymeric sleeve made from sintered gel. The sleeve 710, functions as a diffusion barrier so that when fluid is released from the tubule 720, it is slowed down and allowed to diffuse into the adjacent atrial wall, rather than be released like a jet into the surrounding atrial wall. The sleeve 710 also promotes an equal distribution of fluid throughout the tubule 720.
Figure 8 shows a radial cross section of the tubule shown in Figure 7. Nitinol is a material that may be used for the tubule 720.
Figures 9 and 10 show alternative tubule 910 designs, wherein the micro-ports are filled with porous plugs 920. A preferred porous plug 920 is comprised of sintered gel beads formed into a porous plug.
Figure 11 shows a catheter being introduced from the inferior vena cava 1110, into the S right atrium 1140, through a septum 1120 between the right and left atrium, and into the left atrium 1150. This figure illustrates a pump 1130 positioned within a catheter 1180. Also, there is a guide wire 1170 shown protruding from the distal end of the catheter 1180. The pump 1130 may be a piezoelectric pump used to drive fluid out through the micro-ports of the tubules. In another embodiment, there may be no in-line pump. Instead, an outside pump may be used.
Figure 12 illustrates an embodiment of the invention 1200 that may be used to deliver energy to designated tissue. The device is shown connected to an energy component 1210 that may be a generator, defibrillator, pacemaker, or radio frequency device, that has been positioned underneath the skin (subclavian pocket) and that makes its way into the superior vena cava via the subclavian vein. The device structure 1220 shown within the superior vena cava may function as a transformer, capacitor, or electrode.
Figure 13 shows an embodiment of the invention, and the use of an energy source 1310 to deliver energy to devices of the present invention. The in-line member 1320 could be a transformer, capacitor, or electrode, depending on the need.
Figure 14 shows an embodiment of the invention 1400 having a positioning structure 1410 to standardize scaffold orientation within a treated heart chamber. In this embodiment, the positioning structure 1410 is shown being introduced to a pulmonary vein.
Figures 15 through 18 illustrate various embodiments of the invention.
Figure 15 shows a scaffold in the form of a wire coil that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium in the example shown. The deployed scaffold has an approximately cylindrical configuration. The wire coil of the scaffold may be constructed of a malleable or elastic biocompatible metal, such as stainless steel or a super-elastic or shape memory nickelltitanium alloy, for example.
Preferably, the scaffold is sufficiently flexible such that it does not interfere with the normal contraction of the heart. In addition, the wire coil may have a coating for improved biocompatibility, thermal and/or electrical insulation, etc.
Figure 16 shows another embodiment for the scaffold 1600 of present invention.
The scaffold is in the form of a wire cage that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium. The deployed scaffold may have a dome-shaped or tapered cylindrical configuration, with an upper loop and a lower loop joined by longitudinal struts.
Figure 17 shows another embodiment for the scaffold 1700 of present invention.
The scaffold is in the form of a hoop-and-strut wire cage that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium.
The deployed scaffold may have a dome-shaped or tapered cylindrical configuration, with an upper hoop, a middle hoop and a lower hoop joined by longitudinal struts.
Figures 19 through 22 show various embodiments of the invention having dual chamber structures.
Figures 23-25 show schematic views of a patient with a catheter 2340 being advanced from the inferior vena cava 2330, into the right atrium, and across the septum into the left atrium.
A second catheter 2320 is being advanced through the esophagus 2320, and its close proximity to the left atrium makes it a suitable pathway for delivering a non-contact energy source, such as ultrasound (preferably low frequency ultrasound, below 1 MHz), radio frequency, or an inductive coupling mechanism. Alternative non-contact energy source include microwaves.
These energy sources can be applied to various devices to encourage the flow of ions in a preferred direction, encourage fluid absorption, or cause ablation to occur.
Also, ultrasound and other energy sources may be delivered to the devices of the present invention across the skin, transcutaneously.
While the present invention has been described herein with respect to the exemplary embodiments and the best mode for practicing the invention it will become apparent to one of ordinary skill in the art that many modifications, improvements and sub combinations of the various embodiments, adaptations and variations can be made to the invention without departing from the spirit and scope thereof.
REFERENCE TO PENDING PRIOR PATENT APPLICATION
This patent application claims benefit of pending prior U.S. Provisional Patent Application Serial Number 60/326,590 filed October 1, 2001 by John A.
Macoviak, which patent is hereby incorporated by reference.
FIELD OF THE INVENTION
This invention relates to methods and devices to improve the function of the heart. More particularly, the invention relates to methods and devices to treat atrial fibrillation.
BACKGROUND OF THE INVENTION
To function properly as a pump, the heart must contract in a rhythmic pattern.
Heart rhythm is normally established at a single point called the sinoatrial node, or SA node, located in the right atrium of the heart, near the opening of the superior vena cava. The SA node generates electrical impulses which spread throughout the heart and result in a rhythmic contraction of the heart, termed a sinus rhythm. Thus, the SA node functions as a pacemaker for the heart.
Other regions of the heart can potentially produce electrical impulses. A
pacemaker other than the SA node is referred to as an ectopic pacemaker. Electrical signals from an ectopic pacemaker can disrupt a rhythmically contracting heart, resulting in an arrhythmia, characterized by a chaotic, disorganized heart rhythm. Fibrillation of the atria results in loss of atrial contraction and rapid impulses being sent to the ventricles causing high and irregular heart rates.
Atrial fibrillation (AF) is clinically related to several conditions, including anxiety, increased risk of stroke, reduced exercise tolerance, cardiomyopathy, congestive heart failure and decreased survival. Patients who experience AF are, generally, acutely aware of the symptoms.
Current curative AF therapies are based upon a procedure that has become known as the Cox Maze procedure. The Cox Maze procedure is an open-heart, surgical procedure that requires the patient to be placed on cardiopulmonary bypass equipment. The procedure requires six hours and the patient to be under general anesthesia. In this procedure, access to the heart is gained by way of a median sternotomy, which is a surgical split of the breast bone. The left atrium is surgically incised along predetermined lines known to be effective in blocking the transmission of electrical signals from an ectopic pacemaker that triggers AF.
The incision lines create blocks that prevent conduction of unwanted electrical signals throughout the heart and permit a normal pattern of depolarization of the atria and ventricles beginning in the SA node and traveling to the AV or atrioventricular node.
Less invasive methods and devices for treating AF are needed that improve heart function and improve patient safety.
SUMMARY OF THE INVENTION
The devices of the present invention form a platform, or scaffold for the precise delivery of various forms of energy for treatment of atrial fibrilation. Additionally, the devices of the present invention form a scaffold for the precise delivery of fluids to surrounding tissues. The use of additional energy sources can improve the delivery of various fluids into the surrounding tissue.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows an embodiment of the invention in relation to its position within the heart, and within a patient's body.
Figure 2 shows an enlarged view of the device of Figure 1, with the loops surrounding the outlet of the pulmonary veins 210.
Figure 3 shows the reverse side of the device of Figures l and 2. The reverse side's loop section 320 is shown having a multitude of holes, or micro-ports 330, that lie adjacent to the atrial walls.
Figure 4 shows an embodiment of the invention 400, in fluid communication with a catheter 410.
Figure 5 show an embodiment of the device shown in Figure 4 Figure 6 is a frontal view of the device of Figures 4 and 5, with an additional positioning element.
Figure 7 is a longitudinal cross section of one embodiment of a tubule 720, having several micro-ports 730.
Figure 8 shows a radial cross section of the tubule shown in Figure 7.
Figures 9 and 10 show alternative tubule 910 designs, wherein the micro-ports are filled with porous plugs 920.
Figure 11 shows a catheter being introduced from the inferior vena cava 1110, into the right atrium 1140, through a septum 1120 between the right and left atrium, and into the left atrium 1150.
Figure 12 illustrates an embodiment of the invention 1200 that may be used to deliver energy to designated tissue.
Figure 13 shows an embodiment of the invention, and the use of an energy source 1310 to deliver energy to devices of the present invention.
Figure 14 shows an embodiment of the invention 1400 having a positioning structure 1410 to standardize scaffold orientation within a treated heart chamber.
Figure 15 shows a scaffold in the form of a wire coil that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium in the example shown.
Figure 16 shows another embodiment for the scaffold 1600 of present invention.
The scaffold is in the form of a wire cage that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium.
Figure 17 shows another embodiment for the scaffold 1700 of present invention.
Figure 18 illustrates an alternative embodiment 1800 of the invention, positioned within the right atrium.
Figures 19 through 22 show various embodiments of the invention having dual chamber structures.
Figures 23-25 show schematic views of a patient with a catheter 2340 being advanced from the inferior vena cava 2330, into the right atrium, and across the septum into the left atrium.
A second catheter 2320 is being advanced through the esophagus 2320.
DETAILED DESCRIPTION
Figure 1 shows an embodiment of the invention in relation to its position within the heart, and within a patient's body. The device 100 is comprised of a platform, or scaffold that is shown being introduced from the inferior vena cava 150, into the right atrium 190, across the septum 115 between the right and left atrium, and into the left atrium 180. The device 100 scaffold is shown having a right ablation loop 120, a left ablation loop 130, and an annular base 140. The right and left ablation loops are shown to come within close proximity of the atrial walls that surround the pulmonary veins. The pulmonary veins are common sources of ectopic pacemakers.
S The device 100 is advanced through a catheter 110 and into position.
Alternatively, the device 100 may be pre-loaded within a delivery catheter.
Figure 2 shows an enlarged view of the device of Figure 1, with the loops surrounding the outlet of the pulmonary veins 210. The device may be used as a temporary platform, or scaffold, from which therapeutic fluids or energy can be deployed.
Alternatively, the device may be left in place as a permanent implant.
Although the device 200 may have a gap of incomplete contact between the device and target tissue, the device is still effective, as described below, especially when used conjunction with tissue disrupting energies (electroporation or sonoporation), energies that promote fluid flow (electrophoresis or sonophoresis), and energies that promote scaffold vibrations. Many types of energies can be delivered to the scaffold either directly, or indirectly. Indirect application (using non-contact means) of energies can be applied trans-esophageally, trans-bronchially, trans-tracheally, trans-thoracically, across the sternum, etc.
Figure 3 shows the reverse side of the device of Figures 1 and 2. The reverse side's loop section 320 is shown having a multitude of holes, or micro-ports 330, that lie adjacent to the atrial walls. The micro-ports can be laser cut along the mural facing surface of the device. The micro-ports direct fluids within the device to be released into adjacent tissues. Fluids within the device may include alcohol, potassium iodide, therapeutic drugs, etc.
Alternatively, the devices of the present invention may not have any micro-ports, and instead be used as a heat exchanger. For example, a heat removing fluid could be circulated within the device, thus giving rise to a temporary conduction block in the adjacent tissue. As such, the device 300 can be used a diagnostic tool, for determining the origin of ectopic pacemakers, for example. Also, with longer exposures to adjacent tissues, the heat removal aspect of the device could result in permanent conduction block, tissue shrinkage (to tighten the skin, for promoting valve function, or close off an atrial appendage), etc.
When used in the left atrium, the device's annular base 310 is positioned to surround the mural annulus. The loop section 320 is supported by upright members 315. The loop section 320 is in fluid communication with the catheter via the inlet port 340.
As shown, this device may be used to prevent AF, but in a manner that differs from the Cox Maze procedure. In the Cox Maze procedure, a specific pattern is cut into the heart to create a proper pathway for the signal generated from the SA node to travel throughout the heart. The device shown differs in that it does not create a signal pathway, but rather isolates unwanted signals from propagating. The procedure is intended for use by an interventional electro-cardiologist, or other skilled professional.
Figure 4 shows an embodiment of the invention 400, in fluid communication with a catheter 410. The catheter 410 may be introduced into the femoral vein, and advanced through the vena cava into the right atrium. The catheter may be 12 to 14 French in diameter and approximately 1 SO centimeters long, depending on the dimensions of the patient's anatomy. An exemplary catheter 410 is shown to have a guide wire port 420, a thru lumen port 430, and an ablation agent vent 440. Not shown is an ablation agent inlet port. Preferred ablation agents are alcohol, or potassium iodide.
The catheter may be introduced into the patient under fluoroscopic guidance and advanced through the venous return to the right atrium of the heart. Using standard cardiology procedures, a trans-septal puncture will be performed and the catheter 410 may be advanced through the trans-septal puncture into the left atrium. Guide wires may be advanced into the atrial appendage, the mural valve annulus and one of the pulmonary veins. The device is preferably designed from a biocompatible, super-elastic material that will expand aggressively under the effects of body heat, or with the aid of an inflatable balloon.
Under continued fluoroscopic guidance with the adjunctive capability for verification by intravascular ultrasound, the cardiologist will ensure that the device has expanded completely, and is positioned correctly and in close contact with surrounding heart wall. The device is then used as a platform for the delivery of energy or a fluid that can create a conduction block, or be used diagnostically.
Conduction block lines preferably fully transect the myocardium of the atrium (about 3 to S
millimeters in thickness). Once the conduction block has been completed, the device may be removed from the patient.
The benefits of using alcohol, or other tissue fixative agents, is the drastic reduction of energy required to create conduction block, resulting in a safer and more effective ablation because the tissue is in fact toughened by the fixative properties of alcohol-like agents that cause a coagulation cellular necrosis instead of a weakened tissue wall liquefaction necrosis that is caused with other types of energy to create conduction block.
Figure 5 show an embodiment of the device shown in Figure 4. The device is shown with an opposition member 540, a superior tubule 530 (superior relative to the pulmonary veins), and an inferior tubule 560 (inferior relative to the pulmonary veins). In addition, the device can be designed with additional tubules to create additional lines of ablation, or additional opposition S members. Assuming a traps-septal introduction of this embodiment from the right atrium into the left atrium, the proximal end 520 of the device is positioned adj acent the traps-septal entry point. The opposition member 540 is positioned along the anterior wall, opposite the pulmonary veins. The opposition member functions to transmit mural pressure from the atrium through the device to the tubules. The superior tubule, 530, is positioned adjacent the apex of the left atrium.
The inferior tubule, 560, is positioned adjacent the base of the posterior wall. The tubules, 530 and 560, have a multitude of micro-ports 500. The micro-ports allow a fluid to be released from inside the tubules and into the atrial walls. Several fluids can be used, any of which function to disrupt the flow of unwanted electrical signals. Thus, the fluids released from the micro-ports located along the tubules create an electrical signal block. The shape of signal block created by this embodiment is that of an oval, or a football. The lines follow a path similar to two adjacent longitudinal lines on a world globe (turned sideways) beginning at the North Pole, and ending at the South Pole.
Figure 6 is a frontal view of the device of Figures 4 and 5. An additional aspect of the device includes an orienting structure, so that the device takes advantage of anatomical features to achieve proper orientation within a heart chamber. For example, Figure 6 shows a circular structure 600 projecting from the distal end of the device. This circular projection may be positioned within an atrial appendage to aid with orientation of the device.
This may be designed in the shaped of a pigtail, or corkscrew projecting from the distal end of the device.
Figure 7 is a longitudinal cross section of one embodiment of a tubule 720, having several micro-ports 730. The tubule 720 is encased within a sleeve 710. A
preferred sleeve 710 is a polymeric sleeve made from sintered gel. The sleeve 710, functions as a diffusion barrier so that when fluid is released from the tubule 720, it is slowed down and allowed to diffuse into the adjacent atrial wall, rather than be released like a jet into the surrounding atrial wall. The sleeve 710 also promotes an equal distribution of fluid throughout the tubule 720.
Figure 8 shows a radial cross section of the tubule shown in Figure 7. Nitinol is a material that may be used for the tubule 720.
Figures 9 and 10 show alternative tubule 910 designs, wherein the micro-ports are filled with porous plugs 920. A preferred porous plug 920 is comprised of sintered gel beads formed into a porous plug.
Figure 11 shows a catheter being introduced from the inferior vena cava 1110, into the S right atrium 1140, through a septum 1120 between the right and left atrium, and into the left atrium 1150. This figure illustrates a pump 1130 positioned within a catheter 1180. Also, there is a guide wire 1170 shown protruding from the distal end of the catheter 1180. The pump 1130 may be a piezoelectric pump used to drive fluid out through the micro-ports of the tubules. In another embodiment, there may be no in-line pump. Instead, an outside pump may be used.
Figure 12 illustrates an embodiment of the invention 1200 that may be used to deliver energy to designated tissue. The device is shown connected to an energy component 1210 that may be a generator, defibrillator, pacemaker, or radio frequency device, that has been positioned underneath the skin (subclavian pocket) and that makes its way into the superior vena cava via the subclavian vein. The device structure 1220 shown within the superior vena cava may function as a transformer, capacitor, or electrode.
Figure 13 shows an embodiment of the invention, and the use of an energy source 1310 to deliver energy to devices of the present invention. The in-line member 1320 could be a transformer, capacitor, or electrode, depending on the need.
Figure 14 shows an embodiment of the invention 1400 having a positioning structure 1410 to standardize scaffold orientation within a treated heart chamber. In this embodiment, the positioning structure 1410 is shown being introduced to a pulmonary vein.
Figures 15 through 18 illustrate various embodiments of the invention.
Figure 15 shows a scaffold in the form of a wire coil that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium in the example shown. The deployed scaffold has an approximately cylindrical configuration. The wire coil of the scaffold may be constructed of a malleable or elastic biocompatible metal, such as stainless steel or a super-elastic or shape memory nickelltitanium alloy, for example.
Preferably, the scaffold is sufficiently flexible such that it does not interfere with the normal contraction of the heart. In addition, the wire coil may have a coating for improved biocompatibility, thermal and/or electrical insulation, etc.
Figure 16 shows another embodiment for the scaffold 1600 of present invention.
The scaffold is in the form of a wire cage that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium. The deployed scaffold may have a dome-shaped or tapered cylindrical configuration, with an upper loop and a lower loop joined by longitudinal struts.
Figure 17 shows another embodiment for the scaffold 1700 of present invention.
The scaffold is in the form of a hoop-and-strut wire cage that, when deployed, closely conforms to the interior of a patient's heart chamber, such as the patient's left atrium.
The deployed scaffold may have a dome-shaped or tapered cylindrical configuration, with an upper hoop, a middle hoop and a lower hoop joined by longitudinal struts.
Figures 19 through 22 show various embodiments of the invention having dual chamber structures.
Figures 23-25 show schematic views of a patient with a catheter 2340 being advanced from the inferior vena cava 2330, into the right atrium, and across the septum into the left atrium.
A second catheter 2320 is being advanced through the esophagus 2320, and its close proximity to the left atrium makes it a suitable pathway for delivering a non-contact energy source, such as ultrasound (preferably low frequency ultrasound, below 1 MHz), radio frequency, or an inductive coupling mechanism. Alternative non-contact energy source include microwaves.
These energy sources can be applied to various devices to encourage the flow of ions in a preferred direction, encourage fluid absorption, or cause ablation to occur.
Also, ultrasound and other energy sources may be delivered to the devices of the present invention across the skin, transcutaneously.
While the present invention has been described herein with respect to the exemplary embodiments and the best mode for practicing the invention it will become apparent to one of ordinary skill in the art that many modifications, improvements and sub combinations of the various embodiments, adaptations and variations can be made to the invention without departing from the spirit and scope thereof.
Claims (28)
1. A platform scaffold for treating atrial fibrilation, the platform scaffold comprising:
an annular base, a tubular loop section, upright members, and an inlet port, wherein the annular base supports the loop section via the upright members, and the inlet port enables communication with other devices.
an annular base, a tubular loop section, upright members, and an inlet port, wherein the annular base supports the loop section via the upright members, and the inlet port enables communication with other devices.
2. The platform scaffold of claim 1, further comprising micro-ports positioned along the heart wall contacting surface of the tubular loop section.
3. The platform scaffold of claim 2, wherein the micro-ports are filled with porous plugs.
4. The platform scaffold of claim 1, wherein the platform scaffold is manufactured from a super-elastic material.
5. The platform scaffold of claim 1, wherein the tubular loop section is encased within a polymeric sleeve.
6. A platform scaffold for treating atrial fibrilation, the platform scaffold comprising:
a first structural rail, a second therapeutic rail, and a third therapeutic rail, wherein the rails originate at a first point, and terminate at a second point, and expand radially away from the first point, and contract radially toward the second point, and when placed within a heart chamber, the first structural member transmits force from the surrounding heart wall to the second and third therapeutic rails to ensure all rails contact the adjacent heart wall.
a first structural rail, a second therapeutic rail, and a third therapeutic rail, wherein the rails originate at a first point, and terminate at a second point, and expand radially away from the first point, and contract radially toward the second point, and when placed within a heart chamber, the first structural member transmits force from the surrounding heart wall to the second and third therapeutic rails to ensure all rails contact the adjacent heart wall.
7. The second and third therapeutic rails of claim 6, further comprising micro-ports positioned along the heart wall contacting surface of the rails.
8. The second and third therapeutic rails of claim 7, wherein the micro-ports are filled with porous plugs.
9. The platform scaffold claim 6, wherein the platform scaffold is manufactured from a super-elastic material.
10. The platform scaffold of claim 6, wherein the rails are encased within a polymeric sleeve.
11. The platform scaffold of claim 6, further comprising a positioning member to standardize scaffold orientation within a treated heart chamber.
12. A platform scaffold for treating atrial fibrilation, comprising:
a wire, the wire having an approximately cylindrical configuration when deployed closely conforming to the interior of a patient's heart chamber.
a wire, the wire having an approximately cylindrical configuration when deployed closely conforming to the interior of a patient's heart chamber.
13. The platform scaffold of claim 12, wherein the platform scaffold is manufactured from a super-elastic material.
14. A platform scaffold for treating atrial fibrilation, comprising:
a wire form birdcage, the wire form birdcage having a dome-shaped or tapered cylindrical configuration, with an upper loop and a lower loop joined by longitudinal struts, the wire form birdcage closely conforming to the interior of a patient's heart chamber.
a wire form birdcage, the wire form birdcage having a dome-shaped or tapered cylindrical configuration, with an upper loop and a lower loop joined by longitudinal struts, the wire form birdcage closely conforming to the interior of a patient's heart chamber.
15. The platform scaffold of claim 14, wherein the platform scaffold is manufactured from a super-elastic material.
16. A platform scaffold for treating atrial fibrilation, comprising:
a wire form hoop-and-strut wire cage, the wire form hoop-and-strut wire cage having a dome-shaped or tapered cylindrical configuration, with an upper hoop, a middle hoop and a lower hoop joined by longitudinal struts, the wire form hoop-and-strut wire cage closely conforming to the interior of a patient's heart chamber.
a wire form hoop-and-strut wire cage, the wire form hoop-and-strut wire cage having a dome-shaped or tapered cylindrical configuration, with an upper hoop, a middle hoop and a lower hoop joined by longitudinal struts, the wire form hoop-and-strut wire cage closely conforming to the interior of a patient's heart chamber.
17. The platform scaffold of claim 16, wherein the platform scaffold is manufactured from a super-elastic material.
18. A method of diagnosing signal conduction within the heart comprising:
transvascularly introducing a platform scaffold into the heart;
positioning the platform scaffold;
releasing a heat absorbing fluid into the platform scaffold, the heat absorbing fluid them passing through the platform scaffold;
and observing the effect of localized cooling on the heart to temporarily interrupt signal conduction.
transvascularly introducing a platform scaffold into the heart;
positioning the platform scaffold;
releasing a heat absorbing fluid into the platform scaffold, the heat absorbing fluid them passing through the platform scaffold;
and observing the effect of localized cooling on the heart to temporarily interrupt signal conduction.
19. A method of creating a signal block within the heart comprising:
transvascularly introducing a platform scaffold into the heart having micro-ports;
positioning the platform scaffold;
and releasing a tissue fixative fluid into the scaffold, the tissue fixative fluid then passing through the platform scaffold.
transvascularly introducing a platform scaffold into the heart having micro-ports;
positioning the platform scaffold;
and releasing a tissue fixative fluid into the scaffold, the tissue fixative fluid then passing through the platform scaffold.
20. The method of creating a signal block within the heart of claim 19, further comprising the step of applying tissue disrupting energies that promote fluid flow.
21. The method of creating a signal block within the heart of claim 20, wherein the tissue disrupting energy may be applied directly to the scaffold.
22. The method of creating a signal block within the heart of claim 20, wherein the tissue disrupting energy may be applied indirectly to the scaffold.
23. The method of creating a signal block within the heart of claim 19, further comprising the step of applying energies that promote scaffold vibrations.
24. The method of creating a signal block within the heart of claim 23, wherein the energies that promote scaffold vibrations may be applied directly to the scaffold.
25. The method of creating a signal block within the heart of claim 23, wherein the energies that promote scaffold vibrations may be applied indirectly to the scaffold.
26. A method of creating a signal block within the heart comprising:
transvascularly introducing a platform scaffold into the heart;
positioning the platform scaffold;
and transferring energy to the scaffold to create lines of ablation.
transvascularly introducing a platform scaffold into the heart;
positioning the platform scaffold;
and transferring energy to the scaffold to create lines of ablation.
27. The method of creating a signal block within the heart of claim 26, wherein the energies that creates lines of ablation may be applied directly to the scaffold.
28. The method of creating a signal block within the heart of claim 26, wherein the energies that create lines of ablation may be applied indirectly to the scaffold.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32659001P | 2001-10-01 | 2001-10-01 | |
US60/326,590 | 2001-10-01 | ||
PCT/US2002/031374 WO2003028802A2 (en) | 2001-10-01 | 2002-10-01 | Devices for treating atrial fibrilation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2462254A1 true CA2462254A1 (en) | 2003-04-10 |
Family
ID=23272862
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002455444A Abandoned CA2455444A1 (en) | 2001-10-01 | 2002-10-01 | Methods and devices for heart valve treatments |
CA002462254A Abandoned CA2462254A1 (en) | 2001-10-01 | 2002-10-01 | Devices for treating atrial fibrilation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002455444A Abandoned CA2455444A1 (en) | 2001-10-01 | 2002-10-01 | Methods and devices for heart valve treatments |
Country Status (8)
Country | Link |
---|---|
US (2) | US7291168B2 (en) |
EP (1) | EP1434542A2 (en) |
JP (1) | JP4458845B2 (en) |
CN (2) | CN100333704C (en) |
AU (1) | AU2002362442B2 (en) |
CA (2) | CA2455444A1 (en) |
HK (1) | HK1073423A1 (en) |
WO (1) | WO2003028558A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006223800A (en) * | 2005-02-17 | 2006-08-31 | Sango Sas Di Cattani Rita & C | External support for restoring competence to venous valves by traction of their intercommissural walls |
Families Citing this family (318)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6269819B1 (en) * | 1997-06-27 | 2001-08-07 | The Trustees Of Columbia University In The City Of New York | Method and apparatus for circulatory valve repair |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
WO2006116558A2 (en) * | 1999-04-09 | 2006-11-02 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US7666204B2 (en) | 1999-04-09 | 2010-02-23 | Evalve, Inc. | Multi-catheter steerable guiding system and methods of use |
WO2000060995A2 (en) | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
EP1113497A3 (en) * | 1999-12-29 | 2006-01-25 | Texas Instruments Incorporated | Semiconductor package with conductor impedance selected during assembly |
ITPC20000013A1 (en) * | 2000-04-13 | 2000-07-13 | Paolo Ferrazzi | INTROVENTRICULAR DEVICE AND RELATED METHOD FOR THE TREATMENT AND CORRECTION OF MYOCARDIOPATHIES. |
US8784482B2 (en) * | 2000-09-20 | 2014-07-22 | Mvrx, Inc. | Method of reshaping a heart valve annulus using an intravascular device |
US7691144B2 (en) | 2003-10-01 | 2010-04-06 | Mvrx, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US7527646B2 (en) * | 2000-09-20 | 2009-05-05 | Ample Medical, Inc. | Devices, systems, and methods for retaining a native heart valve leaflet |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
AU2003277115A1 (en) * | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
JP2006501033A (en) * | 2002-10-01 | 2006-01-12 | アンプル メディカル, インコーポレイテッド | Device, system and method for reshaping a heart valve annulus |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US6997950B2 (en) * | 2003-01-16 | 2006-02-14 | Chawla Surendra K | Valve repair device |
US20050107871A1 (en) * | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US7658759B2 (en) * | 2003-04-24 | 2010-02-09 | Cook Incorporated | Intralumenally implantable frames |
US10646229B2 (en) | 2003-05-19 | 2020-05-12 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
WO2004103223A1 (en) * | 2003-05-20 | 2004-12-02 | The Cleveland Clinic Foundation | Apparatus and methods for repair of a cardiac valve |
US8052751B2 (en) * | 2003-07-02 | 2011-11-08 | Flexcor, Inc. | Annuloplasty rings for repairing cardiac valves |
US20050004665A1 (en) * | 2003-07-02 | 2005-01-06 | Lishan Aklog | Annuloplasty rings and methods for repairing cardiac valves |
WO2005007036A1 (en) * | 2003-07-18 | 2005-01-27 | Brivant Research & Development Limited | A device for correcting inversion of the leaflets of a leaflet valve in the heart |
JP4447011B2 (en) * | 2003-07-21 | 2010-04-07 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Percutaneous heart valve |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
EP1734903B2 (en) | 2004-03-11 | 2022-01-19 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
US7942927B2 (en) | 2004-03-15 | 2011-05-17 | Baker Medical Research Institute | Treating valve failure |
EP3143944B1 (en) | 2004-05-14 | 2018-08-01 | Evalve, Inc. | Locking mechanisms for fixation devices |
WO2006002492A1 (en) * | 2004-07-06 | 2006-01-12 | Baker Medical Research Institute | Treating valvular insufficiency |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
JP2008513060A (en) | 2004-09-14 | 2008-05-01 | エドワーズ ライフサイエンシーズ アーゲー | Device and method for treatment of heart valve regurgitation |
CA2581852C (en) | 2004-09-27 | 2012-11-13 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
WO2006041877A2 (en) * | 2004-10-05 | 2006-04-20 | Ample Medical, Inc. | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
SE0403046D0 (en) * | 2004-12-15 | 2004-12-15 | Medtentia Ab | A device and method for improving the function of a heart valve |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
WO2011034628A1 (en) | 2005-02-07 | 2011-03-24 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
WO2006086434A1 (en) | 2005-02-07 | 2006-08-17 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
WO2006089236A1 (en) * | 2005-02-18 | 2006-08-24 | The Cleveland Clinic Foundation | Apparatus and methods for replacing a cardiac valve |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
EP1853199B1 (en) * | 2005-02-28 | 2014-10-29 | Medtentia International Ltd Oy | Devices for improving the function of a heart valve |
WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US20060259135A1 (en) * | 2005-04-20 | 2006-11-16 | The Cleveland Clinic Foundation | Apparatus and method for replacing a cardiac valve |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
CA2606101A1 (en) * | 2005-04-25 | 2006-11-02 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
WO2007025028A1 (en) * | 2005-08-25 | 2007-03-01 | The Cleveland Clinic Foundation | Percutaneous atrioventricular valve and method of use |
CN102113923B (en) | 2005-09-07 | 2014-05-07 | 梅德坦提亚国际有限公司 | A device for improving the function of a heart valve |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7797607B2 (en) * | 2005-12-27 | 2010-09-14 | Lg Electronics, Inc. | DTV transmitter and method of coding main and enhanced data in DTV transmitter |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
US7635386B1 (en) * | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US20070282429A1 (en) * | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
EP2068765B1 (en) | 2006-07-31 | 2018-05-09 | Syntheon TAVR, LLC | Sealable endovascular implants |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US20080033541A1 (en) * | 2006-08-02 | 2008-02-07 | Daniel Gelbart | Artificial mitral valve |
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
FR2906454B1 (en) * | 2006-09-28 | 2009-04-10 | Perouse Soc Par Actions Simpli | IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT. |
US8694077B2 (en) | 2006-10-06 | 2014-04-08 | The Cleveland Clinic Foundation | Apparatus and method for targeting a body tissue |
WO2008070262A2 (en) | 2006-10-06 | 2008-06-12 | The Cleveland Clinic Foundation | Apparatus and method for targeting a body tissue |
SE530568C2 (en) * | 2006-11-13 | 2008-07-08 | Medtentia Ab | Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve |
WO2010004546A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
JP2010511469A (en) * | 2006-12-05 | 2010-04-15 | バルテック カーディオ,リミティド | Segmented ring placement |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US20080208328A1 (en) * | 2007-02-23 | 2008-08-28 | Endovalve, Inc. | Systems and Methods For Placement of Valve Prosthesis System |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8216303B2 (en) * | 2007-11-19 | 2012-07-10 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
WO2010070649A1 (en) | 2008-12-21 | 2010-06-24 | Mor Research Applications Ltd. | Elongated body for deployment in a coronary sinus |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
EP2695587A1 (en) | 2008-01-25 | 2014-02-12 | JenaValve Technology Inc. | Medical apparatus for the therapeutic treatment of an insufficient cardiac valve |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
BR112012021347A2 (en) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US20100121435A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US20100131057A1 (en) | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
US20100121437A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US8262725B2 (en) * | 2008-04-16 | 2012-09-11 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
DK3967274T3 (en) | 2008-04-23 | 2022-10-03 | Medtronic Inc | HEART VALVE DEVICES WITH STENT |
WO2009132187A1 (en) * | 2008-04-23 | 2009-10-29 | Medtronic, Inc. | Stented heart valve devices |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
US8337390B2 (en) * | 2008-07-30 | 2012-12-25 | Cube S.R.L. | Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heart |
CA2776475A1 (en) * | 2008-10-10 | 2010-04-15 | Peter Forsell | An improved artificial valve |
EP2358297B1 (en) | 2008-11-21 | 2019-09-11 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
US8926696B2 (en) | 2008-12-22 | 2015-01-06 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices and adjustment mechanisms therefor |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
EP2633821B1 (en) | 2009-09-15 | 2016-04-06 | Evalve, Inc. | Device for cardiac valve repair |
US20120179184A1 (en) | 2009-09-15 | 2012-07-12 | Boris Orlov | Heart valve remodeling |
US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US20110082538A1 (en) | 2009-10-01 | 2011-04-07 | Jonathan Dahlgren | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
WO2011067770A1 (en) | 2009-12-02 | 2011-06-09 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US9522062B2 (en) * | 2010-02-24 | 2016-12-20 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
ES2761298T3 (en) | 2010-03-05 | 2020-05-19 | Edwards Lifesciences Corp | Retention mechanisms for prosthetic valves |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
EP2558007A4 (en) | 2010-04-13 | 2017-11-29 | Sentreheart, Inc. | Methods and devices for accessing and delivering devices to a heart |
BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
EP2590595B1 (en) | 2010-07-09 | 2015-08-26 | Highlife SAS | Transcatheter atrio-ventricular valve prosthesis |
US8657872B2 (en) | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
WO2012012761A2 (en) | 2010-07-23 | 2012-01-26 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
CN103237523A (en) * | 2010-09-01 | 2013-08-07 | M阀门技术有限公司 | Cardiac valve support structure |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
US9289295B2 (en) | 2010-11-18 | 2016-03-22 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
US9198756B2 (en) | 2010-11-18 | 2015-12-01 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
EP2661239B1 (en) | 2011-01-04 | 2019-04-10 | The Cleveland Clinic Foundation | Apparatus for treating a regurgitant heart valve |
EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
WO2012103173A2 (en) * | 2011-01-25 | 2012-08-02 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US10500038B1 (en) | 2011-05-20 | 2019-12-10 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
EP3395298A1 (en) | 2011-06-27 | 2018-10-31 | University of Maryland, Baltimore | Transapical mitral valve repair device |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
EP2739214B1 (en) | 2011-08-05 | 2018-10-10 | Cardiovalve Ltd | Percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP3656434B1 (en) | 2011-11-08 | 2021-10-20 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
EP2591754B1 (en) * | 2011-11-10 | 2015-02-25 | Medtentia International Ltd Oy | A device and a method for improving the function of a heart valve |
US9445893B2 (en) | 2011-11-21 | 2016-09-20 | Mor Research Applications Ltd. | Device for placement in the tricuspid annulus |
US10143452B2 (en) * | 2011-12-05 | 2018-12-04 | Pi-Cardia Ltd. | Fracturing calcifications in heart valves |
CN104220027B (en) | 2012-01-31 | 2017-11-07 | 米特拉尔维尔福科技有限责任公司 | Bicuspid valve parking device, system and method |
CA2869365A1 (en) * | 2012-04-05 | 2013-10-10 | Mvalve Technologies Ltd. | Cardiac valve support structure |
JP6219377B2 (en) | 2012-05-20 | 2017-10-25 | テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド | Artificial mitral valve |
DE102012010798A1 (en) * | 2012-06-01 | 2013-12-05 | Universität Duisburg-Essen | Implantable device for improving or eliminating heart valve insufficiency |
US9216018B2 (en) | 2012-09-29 | 2015-12-22 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
EP2908743B1 (en) | 2012-10-22 | 2018-08-22 | The Cleveland Clinic Foundation | Apparatus for targeting a body tissue |
EP2911594B1 (en) | 2012-10-23 | 2018-12-05 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US10376266B2 (en) | 2012-10-23 | 2019-08-13 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
CN105007832B (en) | 2013-01-09 | 2018-01-23 | 4科技有限公司 | Organize ancora equipment |
ES2934670T3 (en) | 2013-01-24 | 2023-02-23 | Cardiovalve Ltd | Ventricularly Anchored Prosthetic Valves |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
WO2014136056A1 (en) * | 2013-03-04 | 2014-09-12 | Medical Research, Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Cardiac valve commissure brace |
WO2014141239A1 (en) | 2013-03-14 | 2014-09-18 | 4Tech Inc. | Stent with tether interface |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
WO2014144247A1 (en) | 2013-03-15 | 2014-09-18 | Arash Kheradvar | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
CR20160094A (en) | 2013-08-14 | 2018-03-05 | Mitral Valve Tech Sarl | EQUIPMENT AND METHODS TO IMPLEMENT A REPLACEMENT CARDIAC VALVE |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US10646333B2 (en) | 2013-10-24 | 2020-05-12 | Medtronic, Inc. | Two-piece valve prosthesis with anchor stent and valve component |
US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10258408B2 (en) | 2013-10-31 | 2019-04-16 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US9681864B1 (en) | 2014-01-03 | 2017-06-20 | Harpoon Medical, Inc. | Method and apparatus for transapical procedures on a mitral valve |
EP3107499A4 (en) | 2014-02-20 | 2018-03-14 | Mitral Valve Technologies Sàrl | Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device |
EP4248914A2 (en) | 2014-02-21 | 2023-09-27 | Mitral Valve Technologies Sàrl | Prosthetic mitral valve and anchoring device |
US9572666B2 (en) * | 2014-03-17 | 2017-02-21 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
EP3157469B1 (en) | 2014-06-18 | 2021-12-15 | Polares Medical Inc. | Mitral valve implants for the treatment of valvular regurgitation |
EP3157607B1 (en) | 2014-06-19 | 2019-08-07 | 4Tech Inc. | Cardiac tissue cinching |
CA2958065C (en) | 2014-06-24 | 2023-10-31 | Middle Peak Medical, Inc. | Systems and methods for anchoring an implant |
EP3928743A1 (en) * | 2014-06-26 | 2021-12-29 | Boston Scientific Scimed Inc. | Medical devices and methods to prevent bile reflux after bariatric procedures |
EP3174502B1 (en) | 2014-07-30 | 2022-04-06 | Cardiovalve Ltd | Apparatus for implantation of an articulatable prosthetic valve |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
EP3922213A1 (en) | 2014-10-14 | 2021-12-15 | Valtech Cardio, Ltd. | Leaflet-restraining techniques |
JP6717820B2 (en) | 2014-12-02 | 2020-07-08 | 4テック インコーポレイテッド | Eccentric tissue anchor |
US9517131B2 (en) | 2014-12-12 | 2016-12-13 | Than Nguyen | Cardiac valve repair device |
US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
CN110141399B (en) | 2015-02-05 | 2021-07-27 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with axially sliding frame |
US10231834B2 (en) | 2015-02-09 | 2019-03-19 | Edwards Lifesciences Corporation | Low profile transseptal catheter and implant system for minimally invasive valve procedure |
US10039637B2 (en) | 2015-02-11 | 2018-08-07 | Edwards Lifesciences Corporation | Heart valve docking devices and implanting methods |
US20160235525A1 (en) | 2015-02-12 | 2016-08-18 | Medtronic, Inc. | Integrated valve assembly and method of delivering and deploying an integrated valve assembly |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
WO2016154168A1 (en) * | 2015-03-23 | 2016-09-29 | St. Jude Medical, Cardiology Division, Inc. | Heart valve repair |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
CN107530168B (en) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | Device and method with reduced pacemaker ratio in heart valve replacement |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
WO2017035002A1 (en) * | 2015-08-21 | 2017-03-02 | Twelve Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10034747B2 (en) | 2015-08-27 | 2018-07-31 | Medtronic Vascular, Inc. | Prosthetic valve system having a docking component and a prosthetic valve component |
US20170056215A1 (en) | 2015-09-01 | 2017-03-02 | Medtronic, Inc. | Stent assemblies including passages to provide blood flow to coronary arteries and methods of delivering and deploying such stent assemblies |
WO2017059426A1 (en) | 2015-10-02 | 2017-04-06 | Harpoon Medical, Inc. | Distal anchor apparatus and methods for mitral valve repair |
US10022223B2 (en) | 2015-10-06 | 2018-07-17 | W. L. Gore & Associates, Inc. | Leaflet support devices and methods of making and using the same |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US9872765B2 (en) | 2015-10-12 | 2018-01-23 | Venus Medtech (Hangzhou) Inc | Mitral valve assembly |
US9592121B1 (en) | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN108472135B (en) | 2015-12-10 | 2021-02-02 | 姆维亚克斯股份有限公司 | Devices, systems, and methods for reshaping a heart valve annulus |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
EP3397207A4 (en) | 2015-12-30 | 2019-09-11 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10363130B2 (en) | 2016-02-05 | 2019-07-30 | Edwards Lifesciences Corporation | Devices and systems for docking a heart valve |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
EP3231393B1 (en) | 2016-04-13 | 2023-06-21 | Christian Vallbracht | Minimally invasive implantable mitral and tricuspid valve |
US10624743B2 (en) | 2016-04-22 | 2020-04-21 | Edwards Lifesciences Corporation | Beating-heart mitral valve chordae replacement |
WO2017191549A1 (en) * | 2016-05-05 | 2017-11-09 | LAINCHBURY, John George | Device for the treatment of mitral valve prolapse |
EP3243485A1 (en) | 2016-05-11 | 2017-11-15 | Berlin Heart GmbH | Holding device for a sewing ring |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
WO2017217932A1 (en) * | 2016-06-13 | 2017-12-21 | Singapore Health Services Pte. Ltd. | Device for cardiac valve repair and method of implanting the same |
US10588745B2 (en) | 2016-06-20 | 2020-03-17 | Medtronic Vascular, Inc. | Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
US10828150B2 (en) * | 2016-07-08 | 2020-11-10 | Edwards Lifesciences Corporation | Docking station for heart valve prosthesis |
CA3031187A1 (en) | 2016-08-10 | 2018-02-15 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
US10383725B2 (en) * | 2016-08-11 | 2019-08-20 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, mesh and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
US10722359B2 (en) | 2016-08-26 | 2020-07-28 | Edwards Lifesciences Corporation | Heart valve docking devices and systems |
CR20190069A (en) | 2016-08-26 | 2019-05-14 | Edwards Lifesciences Corp | Heart valve docking coils and systems |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
CR20190308A (en) | 2016-12-20 | 2020-01-24 | Edwards Lifesciences Corp | Systems and mechanisms for deploying a docking device for a replacement heart valve |
WO2018119304A1 (en) | 2016-12-22 | 2018-06-28 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US10653523B2 (en) | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
USD867595S1 (en) | 2017-02-01 | 2019-11-19 | Edwards Lifesciences Corporation | Stent |
US20180256329A1 (en) * | 2017-03-07 | 2018-09-13 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
US10653524B2 (en) | 2017-03-13 | 2020-05-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US10478303B2 (en) | 2017-03-13 | 2019-11-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
EP3595587A4 (en) | 2017-03-13 | 2020-11-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
EP3592288B1 (en) | 2017-03-27 | 2021-09-01 | TruLeaf Medical Ltd. | Docking elements |
US10765515B2 (en) | 2017-04-06 | 2020-09-08 | University Of Maryland, Baltimore | Distal anchor apparatus and methods for mitral valve repair |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
US11065119B2 (en) | 2017-05-12 | 2021-07-20 | Evalve, Inc. | Long arm valve repair clip |
CA3065223A1 (en) | 2017-06-19 | 2018-12-27 | Harpoon Medical, Inc. | Method and apparatus for cardiac procedures |
CR20190571A (en) | 2017-06-30 | 2020-04-19 | Edwards Lifesciences Corp | Docking stations transcatheter valves |
BR112019027404A2 (en) | 2017-06-30 | 2020-07-07 | Edwards Lifesciences Corporation | locking and releasing mechanisms for implantable transcatheter devices |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
USD890333S1 (en) | 2017-08-21 | 2020-07-14 | Edwards Lifesciences Corporation | Heart valve docking coil |
CA3076928A1 (en) | 2017-10-24 | 2019-05-02 | University Of Maryland, Baltimore | Method and apparatus for cardiac procedures |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
CN111655199B (en) | 2018-01-22 | 2023-09-26 | 爱德华兹生命科学公司 | Heart-shaped maintenance anchor |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11517435B2 (en) | 2018-05-04 | 2022-12-06 | Edwards Lifesciences Corporation | Ring-based prosthetic cardiac valve |
AU2019301967A1 (en) | 2018-07-12 | 2021-01-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty systems and locking tools therefor |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
EP3620133A1 (en) * | 2018-09-07 | 2020-03-11 | AVVie GmbH | Implant for improving coaptation of an artrioventricular valve |
US11395738B2 (en) | 2018-09-25 | 2022-07-26 | Truleaf Medical Ltd. | Docking elements |
US11944536B2 (en) * | 2019-08-13 | 2024-04-02 | The Chinese University Of Hong Kong | Transcatheter self-expandable tricuspid valve replacement system |
WO2021084407A1 (en) | 2019-10-29 | 2021-05-06 | Valtech Cardio, Ltd. | Annuloplasty and tissue anchor technologies |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11464634B2 (en) | 2020-12-16 | 2022-10-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors |
US11759321B2 (en) | 2021-06-25 | 2023-09-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN114474029B (en) * | 2022-02-16 | 2023-09-01 | 之江实验室 | High-frequency driven thermal response artificial muscle |
CN117426808B (en) * | 2023-12-21 | 2024-03-08 | 北京华脉泰科医疗器械股份有限公司 | Skirt edge structure, self-adaptive skirt edge bracket, plugging device and skirt edge manufacturing method |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
JPH05184611A (en) | 1991-03-19 | 1993-07-27 | Kenji Kusuhara | Valvular annulation retaining member and its attaching method |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
FR2688692A1 (en) * | 1992-03-20 | 1993-09-24 | Seguin Jacques | Prosthetic ring for reconstruction surgery of the aortic valve |
CN2135346Y (en) * | 1992-09-12 | 1993-06-09 | 中国人民解放军第四军医大学第一附属医院 | Plasticity bicuspid valve shaping ring |
US5263977A (en) * | 1992-10-26 | 1993-11-23 | Angeion Corporation | Electrode spacing device |
FR2708847B1 (en) * | 1993-08-13 | 1995-11-03 | Couetil Jean Paul | Implantable heart valve. |
FR2726657B1 (en) * | 1994-11-07 | 1996-12-06 | Metrix | DEVICE FOR MEASURING AND / OR ANALYZING DISTURBANCES IN THE SECTOR |
US5545241B1 (en) * | 1995-01-17 | 1999-09-28 | Donaldson Co Inc | Air cleaner |
US5716417A (en) * | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
WO1997016135A1 (en) * | 1995-11-01 | 1997-05-09 | St. Jude Medical, Inc. | Bioresorbable annuloplasty prosthesis |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
DE19625202A1 (en) * | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prosthetic mitral heart valve |
DE19624951A1 (en) * | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prosthetic heart valve |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6183411B1 (en) * | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5961440A (en) | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6250308B1 (en) * | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6102932A (en) * | 1998-12-15 | 2000-08-15 | Micrus Corporation | Intravascular device push wire delivery system |
ATE379998T1 (en) * | 1999-01-26 | 2007-12-15 | Edwards Lifesciences Corp | FLEXIBLE HEART VALVE |
WO2000060995A2 (en) * | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US6312464B1 (en) * | 1999-04-28 | 2001-11-06 | NAVIA JOSé L. | Method of implanting a stentless cardiac valve prosthesis |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
SE514718C2 (en) | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6210222B1 (en) * | 1999-12-13 | 2001-04-03 | Eagle Comtronics, Inc. | Coaxial cable connector |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6419695B1 (en) * | 2000-05-22 | 2002-07-16 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heart valve |
ATE381291T1 (en) * | 2000-06-23 | 2008-01-15 | Viacor Inc | AUTOMATIC ANNUAL FOLDING FOR MITRAL VALVE REPAIR |
JP3854045B2 (en) * | 2000-07-25 | 2006-12-06 | オリンパス株式会社 | Endoscope |
US7510572B2 (en) * | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6913608B2 (en) * | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US7070618B2 (en) * | 2000-10-25 | 2006-07-04 | Viacor, Inc. | Mitral shield |
WO2002062408A2 (en) | 2001-02-05 | 2002-08-15 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
US7037334B1 (en) * | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
DE60225303T2 (en) * | 2001-08-31 | 2009-02-26 | Mitral Interventions, Redwood City | DEVICE FOR A HEART LAPSE REPAIR |
US20030120340A1 (en) | 2001-12-26 | 2003-06-26 | Jan Liska | Mitral and tricuspid valve repair |
US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US7112219B2 (en) * | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6945978B1 (en) * | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
-
2002
- 2002-10-01 WO PCT/US2002/031376 patent/WO2003028558A2/en active Application Filing
- 2002-10-01 EP EP02800430A patent/EP1434542A2/en not_active Withdrawn
- 2002-10-01 JP JP2003531900A patent/JP4458845B2/en not_active Expired - Fee Related
- 2002-10-01 CA CA002455444A patent/CA2455444A1/en not_active Abandoned
- 2002-10-01 AU AU2002362442A patent/AU2002362442B2/en not_active Ceased
- 2002-10-01 CN CNB028194756A patent/CN100333704C/en not_active Expired - Fee Related
- 2002-10-01 CA CA002462254A patent/CA2462254A1/en not_active Abandoned
- 2002-10-01 CN CNA2007101271547A patent/CN101108144A/en active Pending
-
2003
- 2003-10-28 US US10/695,433 patent/US7291168B2/en not_active Expired - Lifetime
-
2005
- 2005-08-25 HK HK05107461A patent/HK1073423A1/en not_active IP Right Cessation
-
2007
- 2007-10-25 US US11/977,493 patent/US20080140190A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006223800A (en) * | 2005-02-17 | 2006-08-31 | Sango Sas Di Cattani Rita & C | External support for restoring competence to venous valves by traction of their intercommissural walls |
Also Published As
Publication number | Publication date |
---|---|
US20080140190A1 (en) | 2008-06-12 |
CN100333704C (en) | 2007-08-29 |
CN101108144A (en) | 2008-01-23 |
EP1434542A2 (en) | 2004-07-07 |
CA2455444A1 (en) | 2003-04-10 |
US7291168B2 (en) | 2007-11-06 |
AU2002362442B2 (en) | 2008-08-07 |
HK1073423A1 (en) | 2005-10-07 |
CN1610529A (en) | 2005-04-27 |
JP2005504577A (en) | 2005-02-17 |
US20040138745A1 (en) | 2004-07-15 |
JP4458845B2 (en) | 2010-04-28 |
WO2003028558A8 (en) | 2003-10-30 |
WO2003028558A2 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040243107A1 (en) | Methods and devices for treating atrial fibrilation | |
CA2462254A1 (en) | Devices for treating atrial fibrilation | |
EP1434621A2 (en) | Devices for treating atrial fibrilation | |
US10420606B2 (en) | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen | |
KR102053451B1 (en) | Cerclage atrial implantable cardioverter defibrillators | |
US6925327B2 (en) | Pulmonary vein arrhythmia diagnostic device and method for use | |
US11253698B2 (en) | Method for positioning terminal end of pacemaker lead, which has passed through coronary sinus, in interventricular septum | |
US5104393A (en) | Catheter | |
EP2362798B1 (en) | Shockwave valvuloplasty catheter system | |
EP1602339A1 (en) | Devices, systems, and methods for treating atrial fibrillation | |
US20120290024A1 (en) | Transvenous renal nerve modulation for treatment of hypertension, cardiovascular disorders, and chronic renal diseases | |
US20120290053A1 (en) | Renal nerve stimulation lead, delivery system, and method | |
WO2019234133A1 (en) | Electrophysiology apparatus | |
JP2008540006A (en) | Bistable device, kit and method for the treatment of disorders in the heart rhythm regulation system | |
JP2007511262A (en) | Apparatus, kit and method for treating diseases of heart rate regulation system | |
JP2008540052A (en) | Body cavity shaping device with cardiac leads | |
WO2007022519A2 (en) | Steerable heart implants for congestive heart failure | |
US20120271340A1 (en) | Method and Apparatus for Embolic Protection During Heart Procedure | |
US20120271341A1 (en) | Method and Apparatus for Treating a Mitral Valve Prolapse and Providing Embolic Protection | |
EP3884993A1 (en) | Device for valve regurgitation surgery and cardiac pacemaker lead fixation | |
Burger et al. | Device Therapy of Rhythm Disorders | |
Hansky et al. | First experiences with catheter-guided atrial and ventricular lumenless pacing lead implantation in 28 pediatric patients | |
Bar-Cohen et al. | Age, size and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems | |
WO2017147253A1 (en) | Methods for selective treatment of renal sympathetic nerves | |
Moak et al. | Effectiveness of excimer laser-assisted cardiac pacing and ICD lead extraction in children and young adults |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |